Sign in to view content

Intravitreal Gene Therapy for Neovascular AMD With ADVM-022: Results of the Phase 1 OPTIC Trial

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2020

Related

Intravitreal Bevacizumab vs. Bevacizumab with Dexamethasone for the Treatment of Exudative Age-Related Macular Degeneration
Reda Issa, MD
On Demand Cases, Courses, and Papers
2019
It’s the Patient, Not the Agent: An Assessment of Anti-VEGF Extended Dosing Intervals in Patients With nAMD
David A. Eichenbaum, MD, FASRS
On Demand Cases, Courses, and Papers
2019
New Biomarkers of Angiogenesis in AMD Using OCT Angiography
David Sarraf, MD
Updates from the Field
2017

Category: AMD-Neovascular

See more